These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37251979)

  • 21. Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives.
    Dias MF; Joo K; Kemp JA; Fialho SL; da Silva Cunha A; Woo SJ; Kwon YJ
    Prog Retin Eye Res; 2018 Mar; 63():107-131. PubMed ID: 29097191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ON-bipolar cell gene expression during retinal degeneration: Implications for optogenetic visual restoration.
    Gilhooley MJ; Hickey DG; Lindner M; Palumaa T; Hughes S; Peirson SN; MacLaren RE; Hankins MW
    Exp Eye Res; 2021 Jun; 207():108553. PubMed ID: 33811915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of AAV-Mediated Optogenetic Vision Restoration between Retinal Ganglion Cell Expression and ON Bipolar Cell Targeting.
    Lu Q; Ganjawala TH; Krstevski A; Abrams GW; Pan ZH
    Mol Ther Methods Clin Dev; 2020 Sep; 18():15-23. PubMed ID: 32548211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem cell therapy: a novel approach for vision restoration in retinitis pigmentosa.
    Uy HS; Chan PS; Cruz FM
    Med Hypothesis Discov Innov Ophthalmol; 2013; 2(2):52-5. PubMed ID: 24600643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoring Color Perception to the Blind: An Electrical Stimulation Strategy of Retina in Patients with End-stage Retinitis Pigmentosa.
    Yue L; Castillo J; Gonzalez AC; Neitz J; Humayun MS
    Ophthalmology; 2021 Mar; 128(3):453-462. PubMed ID: 32858064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicology and Pharmacology of an AAV Vector Expressing Codon-Optimized RPGR in RPGR-Deficient Rd9 Mice.
    Song C; Conlon TJ; Deng WT; Coleman KE; Zhu P; Plummer C; Mandapati S; Van Hoosear M; Green KB; Sonnentag P; Sharma AK; Timmers A; Robinson PM; Knop DR; Hauswirth WW; Chulay JD; Shearman MS; Ye GJ
    Hum Gene Ther Clin Dev; 2018 Dec; 29(4):188-197. PubMed ID: 30280954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optical Coherence Tomography (OCT) Diagnostic of Retinitis Pigmentosa - Case Study.
    Adilovic M; Ignjatic E; Cabric A
    Acta Inform Med; 2022 Dec; 30(4):329-333. PubMed ID: 36467319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene panel sequencing in Brazilian patients with retinitis pigmentosa.
    Costa KA; Salles MV; Whitebirch C; Chiang J; Sallum JMF
    Int J Retina Vitreous; 2017; 3():33. PubMed ID: 28912962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optogenetic Approaches to Restoring Vision.
    Pan ZH; Lu Q; Bi A; Dizhoor AM; Abrams GW
    Annu Rev Vis Sci; 2015 Nov; 1():185-210. PubMed ID: 28532375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optopharmacological tools for restoring visual function in degenerative retinal diseases.
    Tochitsky I; Kramer RH
    Curr Opin Neurobiol; 2015 Oct; 34():74-8. PubMed ID: 25706312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic approaches for retinitis pigmentosa].
    Pach J; Gekeler F
    Klin Monbl Augenheilkd; 2013 May; 230(5):512-8. PubMed ID: 23695848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of direct administration of AAV2(CU)hCLN2, a candidate treatment for the central nervous system manifestations of late infantile neuronal ceroid lipofuscinosis, to the brain of rats and nonhuman primates.
    Hackett NR; Redmond DE; Sondhi D; Giannaris EL; Vassallo E; Stratton J; Qiu J; Kaminsky SM; Lesser ML; Fisch GS; Rouselle SD; Crystal RG
    Hum Gene Ther; 2005 Dec; 16(12):1484-503. PubMed ID: 16390279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic challenges to retinitis pigmentosa: from neuroprotection to gene therapy.
    Sahni JN; Angi M; Irigoyen C; Semeraro F; Romano MR; Parmeggiani F
    Curr Genomics; 2011 Jun; 12(4):276-84. PubMed ID: 22131873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artificial vision: needs, functioning, and testing of a retinal electronic prosthesis.
    Chader GJ; Weiland J; Humayun MS
    Prog Brain Res; 2009; 175():317-32. PubMed ID: 19660665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the Electronic Retinal Implant Alpha AMS in Restoring Vision to Blind Patients with End-Stage Retinitis Pigmentosa.
    Edwards TL; Cottriall CL; Xue K; Simunovic MP; Ramsden JD; Zrenner E; MacLaren RE
    Ophthalmology; 2018 Mar; 125(3):432-443. PubMed ID: 29110946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute toxicity study of a simian immunodeficiency virus-based lentiviral vector for retinal gene transfer in nonhuman primates.
    Ikeda Y; Yonemitsu Y; Miyazaki M; Kohno R; Murakami Y; Murata T; Goto Y; Tabata T; Ueda Y; Ono F; Suzuki T; Ageyama N; Terao K; Hasegawa M; Sueishi K; Ishibashi T
    Hum Gene Ther; 2009 Sep; 20(9):943-54. PubMed ID: 19416079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LHON gene therapy vector prevents visual loss and optic neuropathy induced by G11778A mutant mitochondrial DNA: biodistribution and toxicology profile.
    Koilkonda R; Yu H; Talla V; Porciatti V; Feuer WJ; Hauswirth WW; Chiodo V; Erger KE; Boye SL; Lewin AS; Conlon TJ; Renner L; Neuringer M; Detrisac C; Guy J
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(12):7739-53. PubMed ID: 25342621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa.
    Li Y; Tsai YT; Hsu CW; Erol D; Yang J; Wu WH; Davis RJ; Egli D; Tsang SH
    Mol Med; 2012 Dec; 18(1):1312-9. PubMed ID: 22895806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of pathological retinal ganglion cell hyperactivity improves optogenetically evoked light responses in rd1 mice.
    Barrett JM; Degenaar P; Sernagor E
    Front Cell Neurosci; 2015; 9():330. PubMed ID: 26379501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional Availability of ON-Bipolar Cells in the Degenerated Retina: Timing and Longevity of an Optogenetic Gene Therapy.
    Kralik J; Kleinlogel S
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.